Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells

M. Lunova, P. Schwarz, R. Nuraldeen, K. Levada, D. Kuscuoglu, M. Stützle, M. Vujić Spasić, J. Haybaeck, P. Ruchala, M. Jirsa, JC. Deschemin, S. Vaulont, C. Trautwein, P. Strnad,

. 2017 ; 241 (1) : 104-114. [pub] 20161201

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc17023637

Iron is both an essential and a potentially toxic element, and its systemic homeostasis is controlled by the iron hormone hepcidin. Hepcidin binds to the cellular iron exporter ferroportin, causes its degradation, and thereby diminishes iron uptake from the intestine and the release of iron from macrophages. Given that hepcidin-resistant ferroportin mutant mice show exocrine pancreas dysfunction, we analysed pancreata of aging hepcidin knockout (KO) mice. Hepcidin and Hfe KO mice were compared with wild-type (WT) mice kept on standard or iron-rich diets. Twelve-month-old hepcidin KO mice were subjected to daily minihepcidin PR73 treatment for 1 week. Six-month-old hepcidin KO mice showed cytoplasmic acinar iron overload and mild pancreatitis, together with elevated expression of the iron uptake mediators DMT1 and Zip14. Acinar atrophy, massive macrophage infiltration, fatty changes and pancreas fibrosis were noted in 1-year-old hepcidin KO mice. As an underlying mechanism, 6-month-old hepcidin KO mice showed increased pancreatic oxidative stress, with elevated DNA damage, apoptosis and activated nuclear factor-κB (NF-κB) signalling. Neither iron overload nor pancreatic damage was observed in WT mice fed iron-rich diet or in Hfe KO mice. Minihepcidin application to hepcidin KO mice led to an improvement in general health status and to iron redistribution from acinar cells to macrophages. It also resulted in decreased NF-κB activation and reduced DNA damage. In conclusion, loss of hepcidin signalling in mice leads to iron overload-induced chronic pancreatitis that is not seen in situations with less severe iron accumulation. The observed tissue injury can be reversed by hepcidin supplementation. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023637
003      
CZ-PrNML
005      
20170830104010.0
007      
ta
008      
170720s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/path.4822 $2 doi
035    __
$a (PubMed)27741349
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Lunova, Mariia $u Department of Medicine III and IZKF, University Hospital Aachen, Aachen, Germany. Institute of Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
245    10
$a Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells / $c M. Lunova, P. Schwarz, R. Nuraldeen, K. Levada, D. Kuscuoglu, M. Stützle, M. Vujić Spasić, J. Haybaeck, P. Ruchala, M. Jirsa, JC. Deschemin, S. Vaulont, C. Trautwein, P. Strnad,
520    9_
$a Iron is both an essential and a potentially toxic element, and its systemic homeostasis is controlled by the iron hormone hepcidin. Hepcidin binds to the cellular iron exporter ferroportin, causes its degradation, and thereby diminishes iron uptake from the intestine and the release of iron from macrophages. Given that hepcidin-resistant ferroportin mutant mice show exocrine pancreas dysfunction, we analysed pancreata of aging hepcidin knockout (KO) mice. Hepcidin and Hfe KO mice were compared with wild-type (WT) mice kept on standard or iron-rich diets. Twelve-month-old hepcidin KO mice were subjected to daily minihepcidin PR73 treatment for 1 week. Six-month-old hepcidin KO mice showed cytoplasmic acinar iron overload and mild pancreatitis, together with elevated expression of the iron uptake mediators DMT1 and Zip14. Acinar atrophy, massive macrophage infiltration, fatty changes and pancreas fibrosis were noted in 1-year-old hepcidin KO mice. As an underlying mechanism, 6-month-old hepcidin KO mice showed increased pancreatic oxidative stress, with elevated DNA damage, apoptosis and activated nuclear factor-κB (NF-κB) signalling. Neither iron overload nor pancreatic damage was observed in WT mice fed iron-rich diet or in Hfe KO mice. Minihepcidin application to hepcidin KO mice led to an improvement in general health status and to iron redistribution from acinar cells to macrophages. It also resulted in decreased NF-κB activation and reduced DNA damage. In conclusion, loss of hepcidin signalling in mice leads to iron overload-induced chronic pancreatitis that is not seen in situations with less severe iron accumulation. The observed tissue injury can be reversed by hepcidin supplementation. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
650    _2
$a acinární buňky $x metabolismus $7 D061354
650    _2
$a zvířata $7 D000818
650    _2
$a apoptóza $x fyziologie $7 D017209
650    _2
$a cytoplazma $x metabolismus $7 D003593
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a hepcidiny $x nedostatek $x genetika $x fyziologie $7 D064451
650    _2
$a přetížení železem $x komplikace $x metabolismus $x patologie $7 D019190
650    _2
$a makrofágy $x patologie $7 D008264
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a transmisní elektronová mikroskopie $7 D046529
650    _2
$a oxidační stres $x fyziologie $7 D018384
650    _2
$a pankreas $x ultrastruktura $7 D010179
650    _2
$a chronická pankreatitida $x etiologie $x metabolismus $x patologie $7 D050500
655    _2
$a časopisecké články $7 D016428
700    1_
$a Schwarz, Peggy $u Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
700    1_
$a Nuraldeen, Renwar $u Department of Medicine III and IZKF, University Hospital Aachen, Aachen, Germany.
700    1_
$a Levada, Kateryna $u Department of Medicine III and IZKF, University Hospital Aachen, Aachen, Germany.
700    1_
$a Kuscuoglu, Deniz $u Department of Medicine III and IZKF, University Hospital Aachen, Aachen, Germany.
700    1_
$a Stützle, Michael $u Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
700    1_
$a Vujić Spasić, Maja $u Institute of Comparative Molecular Endocrinology, University of Ulm, Ulm, Germany.
700    1_
$a Haybaeck, Johannes $u Institute of Pathology, Medical University of Graz, Graz, Austria.
700    1_
$a Ruchala, Piotr $u Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
700    1_
$a Jirsa, Milan $u Institute of Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
700    1_
$a Deschemin, Jean-Christophe $u INSERM, U1016, Institute Cochin, Paris, France.
700    1_
$a Vaulont, Sophie $u INSERM, U1016, Institute Cochin, Paris, France.
700    1_
$a Trautwein, Christian $u Department of Medicine III and IZKF, University Hospital Aachen, Aachen, Germany.
700    1_
$a Strnad, Pavel $u Department of Medicine III and IZKF, University Hospital Aachen, Aachen, Germany. Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
773    0_
$w MED00002878 $t The Journal of pathology $x 1096-9896 $g Roč. 241, č. 1 (2017), s. 104-114
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27741349 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170830104559 $b ABA008
999    __
$a ok $b bmc $g 1239318 $s 984550
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 241 $c 1 $d 104-114 $e 20161201 $i 1096-9896 $m Journal of pathology $n J Pathol $x MED00002878
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Archiving options